People: Sagent Pharmaceuticals Inc (SGNT.O)

SGNT.O on Nasdaq

27 Nov 2015
Change (% chg)

$0.45 (+3.00%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Behrens, Mary 

Ms. Mary Taylor Behrens is Independent Director of Sagent Pharmaceuticals Inc., since November 2010. .Ms. Behrens has served as a member of our Board since November 2010. Ms. Behrens has been engaged in private consulting since February 2003 and has held the position of President of Newfane Advisors, Inc., a consulting firm, since November 2004. Prior to that, from February 2001 until January 2003, Ms. Behrens served as Head or Co-Head of Merrill Lynch Investment Managers, Americas Region. From February 1998 until January 2001, Ms. Behrens was a Senior Vice President of Merrill Lynch & Co., serving as Head of Human Resources and a member of its Executive Committee. Ms. Behrens served as a member of the board of directors of Manor Care, Inc. from November 2004 until it went private in December 2007. As a result of these and other professional experiences, Ms. Behrens holds a BA in Government from Georgetown University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Frank Kung


Michael Logerfo


Allan Oberman


Thomas Shea


Jonathon Singer


Lorin Drake

As Of  30 Dec 2014
Search Stocks